The Scientist

» retraction and culture

Most Recent

image: Hand Signs for Science

Hand Signs for Science

By | December 5, 2012

Organizations are calling for a common set of sign language for scientific terms.

0 Comments

image: Book Excerpt from Tibet Wild

Book Excerpt from Tibet Wild

By | December 1, 2012

Organizations are calling for a common set of sign language for scientific terms.

0 Comments

image: Playing the Field

Playing the Field

By | December 1, 2012

Organizations are calling for a common set of sign language for scientific terms.

0 Comments

image: Art Through the Nose

Art Through the Nose

By | November 29, 2012

Organizations are calling for a common set of sign language for scientific terms.

3 Comments

image: Opinion: Talking Genomics

Opinion: Talking Genomics

By | November 13, 2012

Organizations are calling for a common set of sign language for scientific terms.

1 Comment

image: Sandy’s Impact on Science

Sandy’s Impact on Science

By | November 5, 2012

Organizations are calling for a common set of sign language for scientific terms.

0 Comments

image: Do Innocent Errors Cause Most Retractions?

Do Innocent Errors Cause Most Retractions?

By | November 2, 2012

Organizations are calling for a common set of sign language for scientific terms.

3 Comments

image: Retraction Backlash

Retraction Backlash

By | November 1, 2012

Organizations are calling for a common set of sign language for scientific terms.

0 Comments

image: Book Excerpt from The Science of Consequences

Book Excerpt from The Science of Consequences

By | November 1, 2012

Organizations are calling for a common set of sign language for scientific terms.

1 Comment

image: Capsule Reviews

Capsule Reviews

By | November 1, 2012

Organizations are calling for a common set of sign language for scientific terms.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech